Paired SARS-CoV-2 Spike Protein Mutations Observed During Ongoing SARS-CoV-2 Viral Transfer from Humans to Minks and Back to Humans

When Viruses Jump Species: Tracking COVID Mutations Between Humans and Minks

In late 2020, the world learned of a troubling development in Denmark: SARS-CoV-2 had spread from humans to farmed minks, mutated within the mink population, and then jumped back to humans carrying new genetic changes. This spillover event raised alarm because animal reservoirs could serve as breeding grounds for new variants that might evade human immunity. This study conducted a detailed genomic analysis of the virus sequences collected during these cross-species transmission events to understand exactly how the spike protein—the key target of most COVID-19 vaccines—was changing.

The researchers analyzed thousands of SARS-CoV-2 genome sequences from both human and mink infections associated with Danish mink farms. They discovered that the mutations in the spike protein did not occur randomly or independently. Instead, specific mutations tended to appear together in pairs, suggesting they were co-selected during the adaptation process. Some of these paired mutations were located in regions of the spike protein that are critical for binding to the ACE2 receptor (the molecular doorway the virus uses to enter cells) and for recognition by antibodies generated by vaccines or natural infection.

One of the most concerning findings was that certain mutation combinations that emerged in minks could potentially alter the virus’s ability to infect human cells or to escape immune recognition. The paired mutations appeared to work synergistically: individually, some mutations had minimal effects, but in combination they produced more significant changes in the spike protein’s structure and function. This co-evolutionary pattern is a hallmark of viral adaptation to a new host, and it demonstrated that the human-mink-human transmission cycle was acting as an evolutionary accelerator for the virus.

The study also mapped these mutations onto the three-dimensional structure of the spike protein to understand their potential functional impact. Several of the paired mutations fell within or near epitopes targeted by neutralizing antibodies, suggesting they could reduce vaccine efficacy. Others affected the receptor-binding domain in ways that might alter the virus’s transmissibility. The structural analysis provided a mechanistic framework for understanding why these particular mutation combinations were being selected during cross-species transmission.

These findings had immediate public health implications. Denmark ultimately culled its entire mink population—approximately 17 million animals—to prevent the further evolution and spread of mink-adapted variants. The study underscored the importance of genomic surveillance at the human-animal interface and highlighted the risks posed by large-scale animal farming operations during a pandemic. It also reinforced the argument for developing vaccines that target conserved viral proteins like the nucleocapsid, which are less susceptible to the kind of rapid spike protein evolution observed in animal reservoirs. The work served as an early warning about the broader challenge of managing a pandemic virus that circulates in multiple host species.